search img
ICOcap Dry powder inhaler - Stevanato Group
ICOcap is our new dry powder inhaler: capsule-based and easy to use. Find out more! Dry powder inhaler ICOcap, Stevanato Group.
Home - Integrated solutions for pharma & healthcare - Stevanato Group > Offering - Stevanato Group > Drug Delivery Systems - Stevanato Group > Proprietary and licensed devices - Stevanato Group > ICOcap Dry powder inhaler - Stevanato Group
page-wrapper

User friendly inhaler for Drug Delivery to the lung

ICOcap is Stevanato's portfolio inhaler offered to the market. It is a device solution for pharmaceutical companies who are focusing on therapeutical disease treatments as asthma and COPD.

Features

  • Reliability due to a robust design
  • For pre-filled drug formulations in size 3 capsules
  • Affordable price
  • Low flow resistance
  • Only 6 injection molded parts, needles and springs

Therapeutic Areas

349_Asthma

Asthma

349A_COPD

COPD

364_pulmonary_disease

Further indications as Cystic Fibrosis, Pulmonary Hypertension, Idiopathic pulmonary fibrosis, etc.

Therapeutic Areas

Benefits

177 Icocap2 Rev01

Patented One-Piece-Design: Cap remains attached when open

275 Projectmanagement

Support in formulation development by our partner Iconovo

141 Customization 2

Optimized size, easy handling

Benefits

SG ICOcap - Inhaler
SG ICOcap - Inhaler

Integrated capabilities

275_project mangm circle
Formulation development by Iconovo
196A_Molding circle
Design for Manufacturing and Production
66_analytical circle
Analytical testing
25_Regulatory circle
Documentation
276_Supplychain circle
Complete supply chain
Interested in ICOcap?
Submit your request